Literature DB >> 17547897

Expectant management of preterm premature rupture of membranes and nonvertex presentation: what are the risks?

David F Lewis1, Alfred G Robichaux, Ronald K Jaekle, Amber Salas, Bernard J Canzoneri, Kelly Horton, Lauren Jaekle, Charles Stedman.   

Abstract

OBJECTIVE: Preterm premature rupture of membranes (PPROM) continues to be a major cause of preterm births. The objective of this study was to compare the morbidity of patients with PPROM nonvertex presentations with patients with PPROM with vertex presentations. STUDY
DESIGN: A retrospective analysis of data from 74 patients with PPROM with nonvertex presentations (study group) and 74 patients with PPROM with vertex presentations (control group) comprised the 2 study groups. All patients that met the study admission criteria were treated in a similar manner at 1 of 3 level-III hospitals. The gestational ages at delivery of all patients were between 23-34 weeks, and the gestational ages between case and control patients were matched for gestational age.
RESULTS: A statistically significant (P = .03) higher incidence of a prolapsed umbilical cord was found in the study group (n = 8; 10.8%) relative to the control group (n = 1; 1.4%). More infants in the study group had low 5-minute Apgar scores (<5) and/or low cord pH (<7.20; n = 25 [33.8%]) than in the control group (n = 12 [16.2%]; P = .02). Five infants with breech presentations underwent a precipitous unplanned vaginal delivery. Significant morbidity was not detected in these 5 infants.
CONCLUSION: After transfer to an antenatal ward, patients with PPROM with nonvertex presentations appear to have a significantly higher risk for prolapsed umbilical cords, lower Apgar scores, and/or lower umbilical cord blood pH values, when compared with their vertex counterparts. Additionally, there appears to be substantial risk of an unintended, vaginal breech delivery.

Entities:  

Mesh:

Year:  2007        PMID: 17547897     DOI: 10.1016/j.ajog.2007.02.023

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

2.  Impact of fetal presentation on pregnancy outcome in preterm premature rupture of membranes.

Authors:  Smitha Joy; Sobha Nair; Radhamany K
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Expectant versus immediate delivery in women with PPROM between 34 and 35+6 weeks: A Retrospective cohort.

Authors:  Shruthi Sreedhar; Swati Rathore; Santosh Benjamin; M Gowri; Jiji E Mathews
Journal:  J Family Med Prim Care       Date:  2020-07-30

4.  An extremely rare case of hand prolapse with preterm premature rupture in the membrane of one twin.

Authors:  Minji Kim; Hye-Joo Lee; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2018-04-11

5.  Progestins Inhibit Interleukin-1β-Induced Matrix Metalloproteinase 1 and Interleukin 8 Expression via the Glucocorticoid Receptor in Primary Human Amnion Mesenchymal Cells.

Authors:  William Marinello; Liping Feng; Terrence K Allen
Journal:  Front Physiol       Date:  2020-07-24       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.